Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw some unusual options trading activity on Wednesday. Investors bought 36,233 call options on the company. This is an increase of approximately 43% compared to the average daily volume of 25,327 call options.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several recent analyst reports. BMO Capital Markets initiated coverage on Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price objective for the company. Bank of America dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a report on Tuesday, November 25th. Evercore ISI decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a report on Thursday, October 30th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Finally, Zacks Research lowered shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Five analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $9.50.

Teladoc Health Stock Up 1.4%

NYSE:TDOC traded up $0.09 during trading hours on Wednesday, reaching $6.16. The company had a trading volume of 3,097,451 shares, compared to its average volume of 5,941,209. Teladoc Health has a twelve month low of $6.03 and a twelve month high of $15.21. The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71. The firm has a market cap of $1.09 billion, a price-to-earnings ratio of -4.82 and a beta of 2.04. The business’s 50-day simple moving average is $7.21 and its two-hundred day simple moving average is $7.72.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The company had revenue of $626.44 million for the quarter, compared to analysts’ expectations of $625.66 million. During the same quarter in the prior year, the firm earned ($0.19) EPS. The business’s revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, equities analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Activity

In related news, insider Fernando M. Rodrigues sold 4,209 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total transaction of $31,483.32. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Charles Divita III sold 17,138 shares of Teladoc Health stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $7.63, for a total transaction of $130,762.94. Following the transaction, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at approximately $1,533,904.68. This trade represents a 7.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 33,288 shares of company stock valued at $251,684 over the last quarter. 0.58% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd purchased a new position in shares of Teladoc Health during the 2nd quarter valued at about $2,722,000. Farther Finance Advisors LLC raised its holdings in Teladoc Health by 424.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock worth $87,000 after purchasing an additional 8,061 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in Teladoc Health in the second quarter worth about $78,000. Wealth Management Associates Inc. bought a new stake in shares of Teladoc Health during the second quarter valued at approximately $509,000. Finally, Strs Ohio purchased a new position in Teladoc Health during the first quarter valued at $349,000. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.